Success Stories: EB-1A Approved for Postdoctoral Scholar in California in the Field of Medicinal Chemistry
Client’s Testimonial:
Thank you very much for your help! I am glad to work with your team and will refer to you anybody I know who is planning to apply for green card.
On June 15, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Scholar in the Field of Medicinal Chemistry (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: June 15, 2015
Processing Time: 23 Days (10 days after Premium Processing was requested)
In this case, the client that we had the opportunity to work with was a postdoctoral scholar from China in the field of medicinal chemistry. Our client’s specialized research has focused on developing novel peptidomimetics that are able to mimic the functions of peptides. His work had resulted in 28 peer-reviewed scientific articles and 6 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 319 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 20 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Any researcher who has made such significant progress in the field as [client] has done is virtually guaranteed to continue producing work of the same or even greater caliber, which is why I feel so strongly that he should continue his work uninterrupted, for the well-being of our mutual field.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of medicinal chemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 23 days.